Start and End Date

01 December 2013-31 December 2018

Coordinator

Asst. Prof. Ebru ERBAY

Project Total Budget

1.5 Milyon Avro

Turkish Partners

Bilkent University

Supported Framework Program

ERC Programme

ufuk_avrupa

Scientific Outputs

METARNAFLAMMATION basic research project was the first ERC project to be accepted in the field of life sciences from Turkey. The project aims to develop new drug targets for the treatment of arteriosclerosis and heart attack based on molecular biology. The project is important for the identification of molecular nods where metabolism and the immune system intersect.

Industrial Innovation (including innovation in services as well as products and processes)

METARNAFLAMMATION project will be useful for elucidating the molecular pathology of many complex diseases such as diabetes, cancer, and arterosclerosis. This ERC project will lead to the development of drugs for cardiovascular diseases, which are the primary causes of mortality in Turkey and will help reducing the economic loss due to these complex diseases.

BAŞARI HİKAYELERİ